13 June, 2025 - London, UK
The 8th edition of the Hybrid AF™ Therapies Summit is taking place in the city of London on June 13, 2025! Join your colleagues for a program covering AF treatment with Hybrid AF™ Therapies.
The program will explore how Hybrid AF™ Therapies are shaping new standards of care in atrial fibrillation advanced treatment.
Led by an international panel of speakers, the event will include sessions and roundtables on latest clinical trial results, best practices, patient selection criteria and procedural considerations.
Audience
Electrophysiologists and Cardiac Surgeons who are interested in developing a Hybrid AF program, or have already started it and would like to further advance their expertise through discussions with peers.
Level
All levels
Faculty
International Faculty
Agenda
The program commences on June 13, from 08:30 until 15:00 CET
Get the preliminary agenda here
Get the booklet here
Topics include:
– Principles and techniques for epicardial ablation and LAA exclusion
– Review of the latest clinical data
– Opportunities and challenges of developing a Hybrid AF program
– The Role of Hybrid Ablation for AF and Non-AF Patients
– Setting up a Hybrid Program
– Hybrid Therapies in Clinical Practice
Venue
Radisson Blu Hotel, London Heathrow, UK
140 Bath Rd, Heathrow, Hayes, London UB3 5AW, United Kingdom
Accommodation
Radisson Blu Hotel, London Heathrow, UK
140 Bath Rd, Heathrow, Hayes, London UB3 5AW, United Kingdom
Hotel bookings will be allocated on an individual basis and you will receive a reservation confirmation by email. Please check your travel details tab in your AF Connect dashboard for your details.
Register your interest for the event here.
8:30 am - 8:30 am
Welcome and Introduction to the Hybrid Summit
8:45 am - 10:15 am
Atrial Fibrillation
Riyaz Kaba, MD– St George’s Hospital, London, UK
Randall Lee–University of California, San Francisco, USA
- Insights on Epi/ Endo Dissociation Natasja de Groot, MD– Erasmus Medical Center, Rotterdam, Netherlands
- Current Studies in Non-Paroxysmal Patients Andreu Porta-Sanchez, MD– Hospital Clínic de Barcelona, Spain
- Why Does Hybrid Therapy Work? Bart van Putte, MD– St Antonius Hospital, Nieuwegein, Netherlands
- Which Patients Benefit From Hybrid Therapies Syed Ahsan, MD– Bart’s Heart Centre, London, UK
- Q&A Open Session With Panelists
10:15 am - 10:45 am
Coffee Break
10:45 am - 2:45 pm
Hybrid AF Therapies
Syed Ahsan, MD– Bart’s Heart Centre, London, UK
Timo Weimar, MD– Cardiac Surgeon, Stuttgart, Germany
- Current Trends in Contemporary Persistent AF Management and Impact of PFA Riyaz Kaba, MD– St George’s Hospital, London, UK
- TT Ablation: Concept, Evidence and Latest Developments Nicolas Doll, MD– Schüchtermann Klinik, Bad Rothenfelde, Germany
- Hybrid Convergent Procedure with LAAE Konstantinos Zanis, MD– Institute Mutualiste Montsouris, Paris, France
- Benefits in LAA Exclusion Andreas Rillig, MD– University Heart and Vascular Center Hamburg (UKE), Hamburg, Germany
- Q&A